BEHAVIORAL DIABETES INSTITUTE
Addressing the Psychosocial Aspects of Diabetes
I'm looking for information about...
For People with Diabetes
For Healthcare Professionals
Community Resources
Scales & Measures
Diabetes Distress Assessment
BDI MONTHLY UPDATES
What's New in June 2025
It's a busy month at BDI!
American Diabetes Association’s 85th Scientific Sessions (Chicago, IL)
June 20 – 23: It will be a busy time for BDI staff at the American Diabetes Association’s 85th Scientific Sessions (Chicago, IL). Exciting new study results to be presented, new projects to be discussed, and old friends to see.
June 21: At the Abbott Diabetes Care booth, Dr. Guzman, BDI Director of Clinical Education, will be moderating the panel discussion, Above the Bias.
June 22: Dr. Polonsky, BDI President, will be speaking on Tell Me Why—Using CGM to Drive Changes in Diabetes Self-Care. He also serves a co-author on six poster presentations on that day:
· Demographic and Clinical Characteristics Associated with Real-World Persistence on Semaglutide for Weight Management in the USA
· How CGM Use Affects Diabetes-Related Attitudes and Behaviors in People with T2D—A Qualitative Investigation
· Treatment Experience of People with Type 2 Diabetes Using Once-Weekly Efsitora in QWINT Phase 3 Trials—A Qualitative Study
· Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real-World Study (BURST)—A Twelve-Month Analysis
· Patient-Reported Outcomes with Use of Inhaled Technosphere Insulin (TI)
· Stability and Impact of Diabetes Distress among Adults with Type 1 Diabetes over Time
June 23: Dr. Fisher, BDI Research Director, will present Reducing Diabetes Distress Leads to Positive Glycemic Change—Results from the EMBARK Trial
In this month’s episode of BDI Briefs, we review a recently published study that examines innovative behavioral interventions, delivered via text messages, designed to improve medication refill adherence. As you will see, we suggest that the negative results of the study highlight the need to focus on people’s feelings and attitudes about their prescribed medications, not just on their behavior. Join Dr. Guzman (BDI Director) of Clinical Education, Dr. Polonsky (BDI President), and Scott Johnson (famed diabetes blogger and a dear BDI friend) for this stimulating discussion.
Study recruitment is almost completed for BDI’s new research project which is investigating an innovative diabetes education program. However, we still have room for a few more people with type 2 diabetes. This opportunity might be right for you if you are ready to get on track with your diabetes, were diagnosed with type 2 diabetes less than 10 years ago, live anywhere in the U.S. and your last A1C was 7.0% or higher.
The study is examining how innovative new approaches to diabetes education might help to improve glucose outcomes and quality of life. Participants will be randomly assigned to take part in one of two different live, online, group education programs. Each group program will be lively and informative, and will meet once weekly for 5 weeks in a row. Also, half of the participants will receive a continuous glucose monitor and free testing supplies. If you are at all interested, don’t delay!
To find out more and see if you might qualify, click below to apply. Or for more information, email us at [email protected] or call us at 858-336-8693.
JOIN US FOR A LOCAL EVENT
Monthly Events
TYPE 2 DIABETES RESEARCH STUDY
Ready to get on a better track with your type 2 diabetes?
BEHAVIORAL DIABETES INSTITUTE
Recent Publications
During 2024, BDI staff authored or co-authored 24 scientific publications (which includes the 3 new ones highlighted above) and 8 published abstracts at major scientific meetings. You can see the full list right HERE. Our work has covered a wide range, including studies on diabetes distress, the value of continuous glucose monitoring (CGM) for people with diabetes, the impact of diabetes medications on quality of life, the benefits of diabetes technology for people with type 1 and type 2 diabetes, diabetes stigma, and more.
Stability and impact of diabetes distress over time: The potential value and uses of the type 1 diabetes distress assessment system (T1-DDAS)
Authors: Danielle M Hessler, William H Polonsky, Lisa Strycker, Diana Naranjo, Katherine Greenberg, Lawrence Fisher Abstract Aims: To document stability and change over time, define a
Validity and reliability of the Turkish version of the type 1 diabetes distress scale
Authors: Tuğba Bi Lgehan, Elif Gencer Şendur, Özlem Canbolat, Emre Dünder, William H Polonsky Abstract Aims: This study aimed to examine the psychometric properties of
WHO WE ARE
Behavioral Diabetes Institute
Behavioral Diabetes Institute (BDI) is a nonprofit organization located in San Diego, California, focused on addressing the social, emotional, and psychological barriers to living a long and healthy life with diabetes. To better understand and overcome these obstacles, BDI is actively engaged in research examining the psychological aspects of diabetes and evaluating innovative behavioral interventions. In addition, BDI directly offers an array of unique, behaviorally-oriented products and services for: people with type 1 diabetes; people with type 2 diabetes; parents of children and teens with diabetes; spouses and partners of people with diabetes; and interested health care professionals. Products and services include print materials; online courses and modules, face-to-face workshops and seminars, professional training programs, and an online library of resources.
